Marijuana: Modern medical chimaera

Journal of Drug Education

Volumn 42, Issue 1, 2012, Pages 1-11

  Lamarine, Roland J ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; DRONABINOL; NABILONE; NABIXIMOLS;

ANOREXIA; ANXIETY; CANNABIS ADDICTION; CARCINOGENESIS; CHIMERA; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG FORMULATION; DRUG INDICATION; HEALTH HAZARD; HEART DISEASE; HUMAN; LUNG INJURY; MENTAL DISEASE; MULTIPLE SCLEROSIS; NAUSEA; OVERACTIVE BLADDER; PAIN; PSYCHOSIS; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SIDE EFFECT; SLEEP DISORDER; SPASTICITY; SYSTEMATIC REVIEW; WITHDRAWAL SYNDROME;

CANNABINOIDS; CANNABIS; CLINICAL TRIALS AS TOPIC; HUMANS; MARIJUANA ABUSE; MUSCLE SPASTICITY; NAUSEA; PAIN; QUALITY OF LIFE; TETRAHYDROCANNABINOL; UNITED STATES;

EID: 84861723516     PISSN: 00472379     EISSN: 15414159     Source Type: Journal    
DOI: 10.2190/DE.42.1.a     Document Type: Review

References (33)

1. Brook, J. S., Balka, E. B., & Whiteman, M. (1999). The risks for late adolescence of early adolescent marijuana use. American Journal of Public Health, 89(10), 1549-1554. (Pubitemid 29457910)
2. Caspari, D. (1999). Cannabis and schizophrenia: Results of a follow-up study. European Archives of Psychiatry and Clinical Neuroscience, 249(1), 45-49. (Pubitemid 29366776)
3. Cohen, P. J. (2010). Medical marijuana 2010: It's time to fix the regulatory vacuum. Journal of Law, Medicine and Ethics, 38(3), 654-666.
4. Crippa, J. A., Zuardi, A. W., Martin-Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., et al. (2009). Cannabis and anxiety: A critical review of the evidence. Human Psychopharmacology, 24, 515-523.
5. Degenhardt, L., & Hall, W. (2006). Is cannabis use a contributory cause of psychosis? Canadian Journal of Psychiatry, 51(9), 566-574.
6. Green, A. J., & DeVries, K. (2010). Cannabis use in palliative care: An examination of the evidence and the implication for nurses. Journal of Clinical Nursing, 19, 2454-2462.
7. Hall, W. (2009). The adverse health effects of cannabis use: What are they, and what are their implications for policy? International Journal of Drug Policy, 20(6), 458-466.
8. Hashibe, M., Tashkin, D. P., Morgenstern, H., Greenland, S., & Zhang, Z. F. (2005). Epidemiologic review of marijuana use and cancer risk. Alcohol, 35(3), 265-275. (Pubitemid 41079926)
9. Julien, R. M. (2005). A primer of drug action. Worth: New York.
10. Kahan, M., & Srivastava, A. (2007). Is there a role for marijuana in medical practice? No. Canadian Family Physician, 53(1), 22-23.
11. Kaiser Permanente Medical Care Plan. (2002). Cardiovascular consequences of marijuana use. Journal of Clinical Pharmacology, 42(11Suppl.), 64S-70S.
12. Kacobay, G., Yildiz, M., Duran, N. E., & Ozkon, M. (2009). Acute inferior myocardial infarction due to cannabis smoking in a young man. Journal of Cardiovascular Medicine, 10(9), 669-670.
13. Kavia, R. B., De Ridder, D., Constantinescu, C. S., Stott, C. G., & Fowler, C. J. (2010). Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. Multiple Sclerosis, 16(11), 1349-1359.
14. Lamarine, R. J., & Sbarbaro, V. (1998). Marijuana abstinence syndrome. American Alliance for Health, Physical Education, Recreation and Dance Conference, Reno, NV.
15. Macleod, J., & Hickman, M. (2010). How ideology shapes the evidence and the policy: What we know about cannabis use and what should we do ? Addiction, 105, 1326-1330.
16. Martin-Sanchez, E., Furukawa, T. A., Taylor, J., & Martin, J. L. (2009). Systematic review and meta-Analysis of cannabis treatment for chronic pain. Pain Medicine, 10(8), 1353-1368.
17. Mathews, A. W. (2010, January 19). Is marijuana a medicine? The Wall Street Journal, p. D1.
18. Medina, K. L., Hanson, K. L., Schweinsburg, S. F., Cohen-Zion, M., Nagel, B. J., & Tapert, S. F. (2007). Neuropsychological functioning in adolescent marijuana users: Subtle deficits detectable after a month of abstinence. Journal of the International Neuropsychological Society, 13(5), 807-820. (Pubitemid 47299450)
19. McGuinness, T. M. (2009). Update on marijuana. Journal of Psychosocial Nursing and Mental Health Services, 47(10), 19-22.
20. Peat, S. (2010). Using cannabinoids in pain and palliative care. International Journal of Palliative Nursing, 16(10), 481-485.
21. Pope, H. G., & Yurgelun-Todd, D. (1996). The residual cognitive effects of heavy marijuana use in college students. Journal of the American Medical Association, 275(7), 521-527. (Pubitemid 26061426)
22. Realini, N., Rubino, T., & Parolaro, D. (2009). Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. Pharmacological Research, 60(2), 132-138.
23. Reece, A. S. (2009). Chronic toxicology of cannabis. Clinical Toxicology, 47(6), 517-524.
24. Selvarajah, D., Emery, C. J., Gandhi, R., & Tesfaye, S. (2010). Randomized placebocontrolled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy. Diabetes Care, 33(1), 128-130.
25. Solowji, H., Stephens, R. S., Roffman, R. A., Babor, T., Kadden, R. M., Christiansen, K., et al. (2002). Cognitive functioning of long-Term heavy cannabis users seeking treatment. Journal of the American Medical Association, 287(9), 1123-1129.
26. Tan, W. C., Lo, C., & Jong, A. (2009). Marijuana and chronic obstructive lung disease: A population-based study. Canadian Medical Association Journal, 180, 814-820.
27. Tashkin, D. P. (2009). Does smoking marijuana increase the risk for chronic obstructive pulmonary disease? Canadian Medical Association Journal, 180(8), 797-798.
28. Tetrault, J. M., Crothers, K., Moore, B. A., Mehra, R., Concato, J., & Fiellin, D. A. (2007). Effects of marijuana smoking on pulmonary function and respiratory complications. Archives of Internal Medicine, 167(3), 221-228.
29. Tormey, W. (2001). Adverse health effects of non-medical cannabis use. Lancet, 375(9710), 196.
30. Wade, D. T., Collin, C., Stott, C., & Duncombe, P. (2010). Meta-Analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis. Multiple Sclerosis, 16(6), 707-714.
31. Wang, T., Collet, J., Shapiro, S., & Ware, M. A. (2008). Adverse effects of medical cannabinoids: A systematic review. Canadian Medical Association Journal, 178(3), 1669-1678. (Pubitemid 351899653)
32. Wu, T. C., Tashkin, D. P., Djahed, B., & Rose, J. E. (1988). Pulmonary hazards of smoking marijuana as compared with tobacco. New England Journal of Medicine, 318(6), 347-351. (Pubitemid 18044163)
33. World Drug Report. (2006). United Nations Office on Drugs and Crime. Retrieved from www.unodc.org/pdf/WDR2006volume1.pdf